Johan Neyts

This inventor holds 28 USPTO granted patents and 12 published patent applications and 14 EPO patents. Top assignees: Katholieke Universiteit Leuven, Korea Research Institute of Chemical Technology, K.u. Leuven Research & Development. Active years: 2006-2026.

USPTO Granted Patents = 28 (Patent Applications = 12)

% Patents Active = 78.6

EPO Patents = 14 (Patent Applications = 24)

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 40(Granted Patents)

Location History:

Kessel Lo, BE (2006 - 2010)
Belgium, BE (2016 - 2018)
Kessel-Lo, BE (2010 - 2024)

Company Filing History:

16 out of 627

Katholieke Universiteit Leuven

patents

8 out of 649

Korea Research Institute of Chemical Technology

patents

6 out of 84

K.u. Leuven Research & Development

patents

4. 5 out of 946

Gilead Sciences, Inc.

patents

5. 2 out of 10

Aratana Therapeutics, Inc.

Aix-Marseille Université

patents

9. 1 out of 2

Aratana Therapeutics Nv

patents

10. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

11. 1 out of 324

Consiglio Nazionale Delle Ricerche

Institute of Organic Chemistry and Biochemistry

patents

14. 1 out of 5

Kemin Pharma B.v.b.a.

patents

15. 1 out of 4

Université D'auvergne Clermont 1

patents

16. 1 out of 1

Universite Francois Rabelais Tours

patent

17. 1 out of 236

Université´ D'aix-Marseille

patents

18. 2 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12702657 - Treatment and prevention of dengue disease (2026-08-11),

2. 12558410 - LASSAVIRUS VACCINES (2026-02-24),

3. 12545709 - CHIMERIC FILOVIRUS VACCINES (2026-02-10),

4. 12286423 - Antiviral 1,3-di-oxo-indene compounds (2025-04-29),

5. 12083092 - Antiviral 1,3-di-oxo-indene compounds (2024-09-10),

6. 12070494 - Chimeric flavivirus lyssavirus vaccines (2024-08-27),

7. 11904024 - Eye drop composition (2024-02-20),

8. 11680084 - Live-attenuated flaviruses with heterologous antigens (2023-06-20),

9. 11351240 - Chimeric yellow fever ZIKA virus strain (2022-06-07),

10. 10967074 - Eye drop composition (2021-04-06),

11. 9951058 - Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (2018-04-24),

12. 9890133 - Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (2018-02-13),

13. 9833423 - 1,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (2017-12-05),

14. 9790197 - Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (2017-10-17),

15. 9464067 - Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (2016-10-11),

Title: The Innovative Journey of Inventor Johan Neyts

Introduction: Johan Neyts, a talented inventor hailing from Kessel-Lo, Belgium, has made significant contributions to the field of innovation with his groundbreaking ideas and inventions.

Latest Patents: Johan Neyts has recently been granted patents for his cutting-edge inventions in the field of biotechnology and medical devices, showcasing his continuous commitment to pushing the boundaries of innovation.

Career Highlights: With a career spanning over two decades, Johan Neyts has established himself as a prominent figure in the world of inventors. His innovative solutions have revolutionized the way we approach challenges in various industries, earning him recognition and respect from his peers.

Collaborations: Throughout his career, Johan Neyts has collaborated with leading research institutions, universities, and companies to further develop and commercialize his inventions. His ability to work effectively in multidisciplinary teams has been instrumental in bringing his ideas to life.

Conclusion: In conclusion, Johan Neyts stands as a testament to the power of innovation and perseverance. His passion for creating solutions to complex problems has not only shaped his own career but has also left a lasting impact on the world of inventions.